Clinical Trial Update: Behavioral and/or Mirabegron to Treat Urinary Symptoms in Parkinson Disease [Phase 4]

View source ↗

Summary

This ClinicalTrials.gov entry updates a Phase 4 study evaluating behavioral interventions and/or mirabegron to treat urinary symptoms in Parkinson's disease. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Parkinson Disease

Drugs mentioned

• Mirabegron (mirabegron)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Overactive Bladder, Parkinson Disease | Phase 4 | Status: NOT_YET_RECRUITING